fiber aids digestion semaglutide Hydration, & Digestion: Preventing Constipation on GLP-1 Nutrition While on Semaglutide

On 1 April 2026, the FDA approved Foundayo (orforglipron) for adults with obesity or overweight with weight-related medical conditions, making it the first small-molecule oral GLP-1 receptor agonist to receive regulatory clearance anywhere in the world

One bottle = exactly 4 weeks of supply, precision-engineered with zero overshoot

Follow the proper administration technique provided by your healthcare provider or pharmacist

Ideal for anyone looking to boost antioxidant protection and maintain healthy immune function

Many patients transition to a maintenance schedule of one shot every 2 to 4 weeks rather than stopping completely